These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

388 related items for PubMed ID: 22998451

  • 1. P-glycoprotein, breast cancer resistance protein, Organic Anion Transporter 3, and Transporting Peptide 1a4 during blood-brain barrier maturation: involvement of Wnt/β-catenin and endothelin-1 signaling.
    Harati R, Benech H, Villégier AS, Mabondzo A.
    Mol Pharm; 2013 May 06; 10(5):1566-80. PubMed ID: 22998451
    [Abstract] [Full Text] [Related]

  • 2. Susceptibility of juvenile and adult blood-brain barrier to endothelin-1: regulation of P-glycoprotein and breast cancer resistance protein expression and transport activity.
    Harati R, Villégier AS, Banks WA, Mabondzo A.
    J Neuroinflammation; 2012 Dec 19; 9():273. PubMed ID: 23253775
    [Abstract] [Full Text] [Related]

  • 3. Induction of P-glycoprotein and Bcrp at the rat blood-brain barrier following a subchronic morphine treatment is mediated through NMDA/COX-2 activation.
    Yousif S, Chaves C, Potin S, Margaill I, Scherrmann JM, Declèves X.
    J Neurochem; 2012 Nov 19; 123(4):491-503. PubMed ID: 22845665
    [Abstract] [Full Text] [Related]

  • 4. Functional characterization of mouse organic anion transporting peptide 1a4 in the uptake and efflux of drugs across the blood-brain barrier.
    Ose A, Kusuhara H, Endo C, Tohyama K, Miyajima M, Kitamura S, Sugiyama Y.
    Drug Metab Dispos; 2010 Jan 19; 38(1):168-76. PubMed ID: 19833843
    [Abstract] [Full Text] [Related]

  • 5. Multiple human isoforms of drug transporters contribute to the hepatic and renal transport of olmesartan, a selective antagonist of the angiotensin II AT1-receptor.
    Yamada A, Maeda K, Kamiyama E, Sugiyama D, Kondo T, Shiroyanagi Y, Nakazawa H, Okano T, Adachi M, Schuetz JD, Adachi Y, Hu Z, Kusuhara H, Sugiyama Y.
    Drug Metab Dispos; 2007 Dec 19; 35(12):2166-76. PubMed ID: 17823233
    [Abstract] [Full Text] [Related]

  • 6. Role of transporters in the disposition of the selective phosphodiesterase-4 inhibitor (+)-2-[4-({[2-(benzo[1,3]dioxol-5-yloxy)-pyridine-3-carbonyl]-amino}-methyl)-3-fluoro-phenoxy]-propionic acid in rat and human.
    Kalgutkar AS, Feng B, Nguyen HT, Frederick KS, Campbell SD, Hatch HL, Bi YA, Kazolias DC, Davidson RE, Mireles RJ, Duignan DB, Choo EF, Zhao SX.
    Drug Metab Dispos; 2007 Nov 19; 35(11):2111-8. PubMed ID: 17686907
    [Abstract] [Full Text] [Related]

  • 7. Differential regulation of transport proteins in the periinfarct region following reversible middle cerebral artery occlusion in rats.
    Dazert P, Suofu Y, Grube M, Popa-Wagner A, Kroemer HK, Jedlitschky G, Kessler C.
    Neuroscience; 2006 Nov 03; 142(4):1071-9. PubMed ID: 16997484
    [Abstract] [Full Text] [Related]

  • 8. Quantitative evaluation of the impact of active efflux by p-glycoprotein and breast cancer resistance protein at the blood-brain barrier on the predictability of the unbound concentrations of drugs in the brain using cerebrospinal fluid concentration as a surrogate.
    Kodaira H, Kusuhara H, Fujita T, Ushiki J, Fuse E, Sugiyama Y.
    J Pharmacol Exp Ther; 2011 Dec 03; 339(3):935-44. PubMed ID: 21934030
    [Abstract] [Full Text] [Related]

  • 9. Regulation of Blood-Brain Barrier Transporters by Transforming Growth Factor-β/Activin Receptor-Like Kinase 1 Signaling: Relevance to the Brain Disposition of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors (i.e., Statins).
    Betterton RD, Abdullahi W, Williams EI, Lochhead JJ, Brzica H, Stanton J, Reddell E, Ogbonnaya C, Davis TP, Ronaldson PT.
    Drug Metab Dispos; 2022 Jul 03; 50(7):942-956. PubMed ID: 35504656
    [Abstract] [Full Text] [Related]

  • 10. Organic anion transporter 3 mediates the efflux transport of an amphipathic organic anion, dehydroepiandrosterone sulfate, across the blood-brain barrier in mice.
    Miyajima M, Kusuhara H, Fujishima M, Adachi Y, Sugiyama Y.
    Drug Metab Dispos; 2011 May 03; 39(5):814-9. PubMed ID: 21325432
    [Abstract] [Full Text] [Related]

  • 11. Sex-specific differences in organic anion transporting polypeptide 1a4 (Oatp1a4) functional expression at the blood-brain barrier in Sprague-Dawley rats.
    Brzica H, Abdullahi W, Reilly BG, Ronaldson PT.
    Fluids Barriers CNS; 2018 Sep 13; 15(1):25. PubMed ID: 30208928
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Functional Expression of P-glycoprotein and Organic Anion Transporting Polypeptides at the Blood-Brain Barrier: Understanding Transport Mechanisms for Improved CNS Drug Delivery?
    Abdullahi W, Davis TP, Ronaldson PT.
    AAPS J; 2017 Jul 13; 19(4):931-939. PubMed ID: 28447295
    [Abstract] [Full Text] [Related]

  • 14. Organic anion transporter 3- and organic anion transporting polypeptides 1B1- and 1B3-mediated transport of catalposide.
    Jeong HU, Kwon M, Lee Y, Yoo JS, Shin DH, Song IS, Lee HS.
    Drug Des Devel Ther; 2015 Jul 13; 9():643-53. PubMed ID: 25653502
    [Abstract] [Full Text] [Related]

  • 15. [¹¹C]befloxatone brain kinetics is not influenced by Bcrp function at the blood-brain barrier: a PET study using Bcrp TGEM knockout rats.
    Hosten B, Boisgard R, Jacob A, Goutal S, Saubaméa B, Dollé F, Scherrmann JM, Cisternino S, Tournier N.
    Eur J Pharm Sci; 2013 Nov 20; 50(3-4):520-5. PubMed ID: 23981334
    [Abstract] [Full Text] [Related]

  • 16. Investigation of efflux transport of dehydroepiandrosterone sulfate and mitoxantrone at the mouse blood-brain barrier: a minor role of breast cancer resistance protein.
    Lee YJ, Kusuhara H, Jonker JW, Schinkel AH, Sugiyama Y.
    J Pharmacol Exp Ther; 2005 Jan 20; 312(1):44-52. PubMed ID: 15448171
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Regulation of hepatic drug transporter activity and expression by organochlorine pesticides.
    Bucher S, Le Vee M, Jouan E, Fardel O.
    J Biochem Mol Toxicol; 2014 Mar 20; 28(3):119-28. PubMed ID: 24464585
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Activation of beta-catenin signalling by GSK-3 inhibition increases p-glycoprotein expression in brain endothelial cells.
    Lim JC, Kania KD, Wijesuriya H, Chawla S, Sethi JK, Pulaski L, Romero IA, Couraud PO, Weksler BB, Hladky SB, Barrand MA.
    J Neurochem; 2008 Aug 20; 106(4):1855-65. PubMed ID: 18624906
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.